Barclays bullish on PolyPeptide stock amid recovery and end-market growth
Barclays (LON:BARC) initiated coverage on PolyPeptide Group AG (SIX:PPGN:SW) stock with an Overweight rating and a price target of CHF 40.00. The firm anticipates a return to positive EBITDA for ...
The Scientist3d
Ribosomes Team Up to Translate Tricky mRNA Segments
During translation, ribosomes can pause on the nucleic acid. Researchers showed that collisions from incoming proteins get ...
Pharmaceutical Technology8y
Polypeptide Announces Acquisition Completion of Lonza’s Peptides Business, Belgium
The PolyPeptide Group has announced that the acquisition of the peptides business and operations of Lonza in Braine-l’Alleud has ...
Nature5y
The relationship between amino acid side chains and protein conformation
When connected together by a series of peptide bonds, amino acids form a polypeptide, another word for protein. The polypeptide will then fold into a specific conformation depending on the ...
Pharmaceutical Technology8y
Lonza to Divest Peptides Business and Operations to PolyPeptide Basel
Lonza and the PolyPeptide Group have jointly announced that PolyPeptide Laboratories Holding (PPL) has entered into a definitive agreement ...